# LLM call: summary

- Turn: 5
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 868
- Completion tokens: 226
- Total tokens: 1094
- Cost (USD): 0.000132

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1237: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn to mid-2028: dormant grid-relay access and OT tooling prompted segmentation, rotation and 24h reporting, backed by France, Germany, Spain, Poland, but implementation lagged over costs, grid queues and state-aid disputes. Winter-spring genome-model pathogen spread, ICUs filled; DG SANTE/HERA gained stockpiles, federated sequencing and reporting, same four states first, but sequencing underfunded, screening evaded via non-EU brokers. September leak of agent-coordination logs collapsed trust in voluntary testing; Commission mandated retention/disclosure of traces and pre-release evaluations enforced by AI Office with JRC/ENISA. Jan-June 2028: labs complied in form via data rooms while lobbying to limit scope to future models, completeness contested. Bio surge declared operational and wards emptied, though coverage patchy and staffing thin. New Displacement Buffer offered wage insurance/retraining via ESF+ and automation levies to ease data-centre opposition, but Spanish/Dutch councils withheld consent; gigafactories survived on guarantees amid lengthening queues. By June lights on, containment held, audits pending, but municipal blockades and job anger blocked siting — time bought, not consent.

CURRENT NARRATIVE:
### Traces, sequences, and votes
July to December 2028 arrived with three shocks the Commission had not budgeted together.

The audit mandate formally closed. The Independent Incident Audit Authority became operational, with AI Office case teams, Joint Research Centre evaluators and ENISA forensics holding data rooms in Paris, Munich and Dublin. Providers serving the Union kept market access in exchange for retaining agent-coordination traces and pre-release test records. In practice compliance stayed partial: logs arrived redacted, historic runs were declared out of scope, and completeness fights moved from Parliament hearings to technical working groups. Disclosure was better than voluntary testing, far from verifiable.

Public health held its breath again. A contested paper claimed a genome model had helped a non-expert team toward a viable human-infecting design. Methodologists quarrelled, the authors were accused of alarmism and of publishing too much, but HERA and national labs treated it as a step-change signal. Federated sequencing and stockpiles built in spring stayed staffed on bridging funds, yet hospital sequencing gaps and orders routed through brokers outside the Union remained open. A new synthesis-screening regulation requiring verified customer checks and refusal rules for any order touching the Union, plus uplift tests for genome models, was tabled on an internal-market base. Industry warned of delays; health ministers pushed.

Grid politics hardened. Spanish and Dutch councils still withheld permits for gigafactory hookups, demanding wage-insurance cash before pylons. The Displacement Buffer ran pilots, gigafactories lived on guarantees, queues lengthened. A genuine advance in automated patching and swarm detection helped operators close one class of grid intrusion faster, and segmentation held the lights on.

Then Washington voted. The American election returned a president committed to holding advanced AI as a strategic asset, with tiered foreign access and tighter export review. No new terms applied yet, but in Brussels the result read as humiliation: editorials asked what sovereignty meant if access is decided elsewhere. Municipal blockades and job anger fused with that mood.
```

## Raw response

```
July-Dec 2028: audit mandate closed and Independent Incident Audit Authority became operational with AI Office, JRC and ENISA data rooms in Paris, Munich, Dublin; providers kept market access for retaining traces/test records but compliance stayed partial with redactions and out-of-scope historic runs. Contested paper claiming genome model aided non-expert toward viable human-infecting design treated by HERA/labs as step-change despite methodological dispute; federated sequencing/stockpiles continued on bridging funds but gaps and non-EU broker evasion persisted, prompting tabled synthesis-screening regulation with verified checks, refusal rules and uplift tests. Spanish/Dutch councils continued to block gigafactory hookups demanding wage-insurance payouts; Displacement Buffer only pilots, queues lengthened, though automated patching/swarm detection and segmentation kept grid stable. US election returned president pledging to hold advanced AI as strategic asset with tiered foreign access/tighter export review, fueling EU sovereignty humiliation narrative merging with municipal blockades and job anger.
```
